Company: ORBS
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001641172-25-004802
Chunk: 1310

Company: Eightco Holdings Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 7A
Chunk 1310
---
000 shares
for each doubling in market capitalization of the Company over the market capitalization recorded at the prior bonus threshold, provided
such increase is sustained for a period of at least three consecutive trading days. Though specific milestone thresholds and timing requirements
vary, the March Vroman Agreement contained a substantially similar provision with respect to a continuing market capitalization bonus.
Mr. Vroman may also be eligible for additional compensation in the sole and complete discretion of the Board.

Mr.
Vroman will be eligible to participate in all health, medical, dental and life insurance policies offered to employees of the Company,
and the Company will pay all applicable premiums. The Company will reimburse Mr. Vroman up to $10,000 per year as a car allowance, reimburse
Mr. Vroman up to $2,500 for home office expenses and reimburse Mr. Vroman for all reasonable out-of-pocket expenses incurred by him in
the conduct of the Company’s business. The Vroman Employment Agreement provides Mr. Vroman with four (4) weeks of paid vacation
and five (5) days of paid personal time. The Vroman Employment Agreement also provides Mr. Vroman with liability insurance coverage and
shall reimburse certain financial planning expenses incurred by Mr. Vroman. All terms provided in this paragraph are substantially similar
to those provided in the March Vroman Agreement.

53

In
the event the Company terminates Mr. Vroman’s employment without cause (as defined in the Vroman Employment Agreement), Mr. Vroman
will receive (i) the Accrued Obligation (as defined in the Vroman Employment Agreement) and (ii) severance in the amount of equal to
the Vroman Base Salary for twenty-four (24) months. In addition, this termination will cause the vesting of all Eightco common stock
held by Mr. Vroman and entitle Mr. Vroman to reimbursement of premiums associated with the continuation of health insurance benefits
provided under the Vroman Employment Agreement during the remaining Term of Employment (as defined in the Vroman Employment Agreement).

On
February 26, 2024, the Company and Brett Vroman entered into General Release and Severance Agreement (the “Vroman Severance Agreement”),
effective as of the eighth date following the Vroman Severance Agreement in connection with the termination of the amended and restated
employment agreement, by and between the Company and Mr. Vroman, effective as of September 27, 2022. Pursuant to the Vroman Severance
Ag